Brian Gemmell, a fitness instructor, said he only had an odd swelling in his fingertips before his doctor diagnosed him with ...

Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Lung cancer is one of the most common and serious types of cancer - and the symptoms often don't become apparent until the ...

A fit and healthy mother of-two has revealed the early sign of lung cancer that put down to an exercise injury — 'aching' pain in her shoulder. Despite never smoking, Reyna Savage, from ...

Apr. 2, 2025 — Lung cancer screening has the potential to catch lung cancer early and save lives -- but only if people get screened. Although lung cancer screening ... A Post-Treatment Blood ...

May 8, 2025 — A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve ...

SAN ANTONIO - There is new technology in the fight against the spread of lung cancer. And it comes in the form of a robot, which helps to navigate and diagnose this type of cancer in patients.

US FDA Approves AbbVie's Drug for a Type of Lung Cancer (Reuters) -The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Dr. John Lazar with Ascension Saint Thomas said the imaging agent known as Cytalux helps doctors see cancerous cells they may have missed. NASHVILLE, Tenn. (WTVF) — More than 225,000 Americans ...

A cancer patient who was ready to fly halfway across the country for a potentially life-saving double lung transplant has said he was denied insurance coverage at the last second. Married father ...

Despite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just drug research. The new Lung Ambition Alliance – launched in July ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...